Adderall off the Canadian market

Canada's health regulatory agency, Health Canada, requested that Shire stop selling their drug Adderall on the Canadian market. Shire's biggest market for the drug is in the US, with $759 mil in sales last year, as opposed to $10 mil in Canada. The drug is an amphetamine, a stimulant, used to treat attention deficit disorder. Health Canada pulled the drug because of cases of sudden death and stroke. The FDA viewed the same data as inconsequential. A Senator is alleging that the FDA tried to convince Health Canada not to pull the drug, because it could not take on another "drug safety crisis".

read
more: read